麻豆社

Talent Prize 2025

Adelina Yafasova

Cardiovascular diseases: Adelina thinks across multiple conditions

Physician, PhD student
Department of Cardiology, Rigshospitalet

When conducting research on the relatively rare disease cardiac sarcoidosis, it is important to think across organ systems. Adelina Yafasova has done so by collaborating with colleagues from many different medical fields.

鈥淚t鈥檚 really exciting to look at how the organs interact 鈥 that you can have an illness in one part of the body that can also lead to heart disease, either as a result of the illness itself or its treatment.鈥

So says Adelina Yafasova, PhD student at the Department of Cardiology at Rigshospitalet and recipient of the Lundbeck Foundation Talent Prize 2025. She began doing research during the bachelor鈥檚 part of her medical studies, and her research has already introduced her to several medical specialties.

鈥淚 don鈥檛 really see myself as a cardiology experimentalist. I see myself as an interdisciplinary researcher 鈥 someone who studies diseases outside the heart and examines how these diseases affect the risk of developing heart disease,鈥 says Adelina Yafasova.

鈥淚t鈥檚 interesting to work with this patient group because they often fall between two chairs and can become very frustrated, as their condition is difficult to diagnose. They risk being overlooked because we as doctors are sometimes very focused on precisely the area, we specialize in.鈥

Testing a new scan for cardiac sarcoidosis

At Rigshospitalet, Adelina Yafasova has conducted research on, among other things, stroke, heart failure treatment using an implantable cardioverter-defibrillator (ICD), and sarcoidosis 鈥 an autoimmune disease that can affect multiple organs, including the heart.

By using national registries in her research, she has shown that sarcoidosis, lupus, and other autoimmune diseases increase the long-term risk of developing cardiovascular disease. This had previously only been shown in small studies, so her registry studies have also attracted international attention.

PET scan
Adelina is investigating the value of a PET scan with a new type of tracer to detect cardiac sarcoidosis. Stock photo of a PET scan.

鈥淥ur results have helped doctors pay increased attention to cardiovascular disease when they see patients with, for example, sarcoidosis or lupus 鈥 so that these patients can be referred to a cardiology department if relevant,鈥 says Adelina Yafasova.

Cardiac sarcoidosis can be difficult to diagnose because its symptoms can resemble those of other conditions. Therefore, Adelina Yafasova has conducted a clinical study testing a new type of scan to diagnose patients with cardiac sarcoidosis 鈥 specifically, a PET scan with a new type of tracer. All patients for the study have now been included, and she is about to analyze the results.

鈥淲e very much hope that this new type of scan can improve our ability to detect cardiac sarcoidosis so that patients can begin treatment earlier and improve their chances of survival. It鈥檚 a very serious disease that we still don鈥檛 know enough about,鈥 says Adelina Yafasova.

She also hopes that, over time, it will become possible to establish a national and international database of patients with cardiac sarcoidosis, which could help fill existing knowledge gaps and later be used to design new studies on the disease.

Cancer and cardiovascular disease

Adelina Yafasova has also embarked on another research area that aligns with her interdisciplinary interests: the increased risk of cardiovascular disease among cancer survivors. While short-term risks are known, long-term risks are not well documented.

鈥淚t鈥檚 an important but also overlooked topic that鈥檚 becoming increasingly relevant because treatment for many cancers has improved so much. There鈥檚 now a large group of patients who survive cancer but live with late effects from the treatment or the disease itself. For example, side effects from chemotherapy can damage the heart,鈥 says Adelina Yafasova.

If we want to inspire people to go into research in the long term, it鈥檚 important to create good conditions that make it possible
 
Adelina Yafasova

She has already entered collaboration with oncologists and haematologists on this topic. Together, they are now investigating the risk of various types of cardiovascular disease among long-term cancer survivors. In the future, they also hope to explore how to prevent cardiovascular disease in this group 鈥 and whether certain patients might benefit particularly from preventive measures.

Aiming to buy time for research

During her PhD studies, Adelina Yafasova became a mother of two. She has therefore also experienced the challenges of balancing a research career with family life.

鈥淚 have to make tough priorities and make compromises, because you can鈥檛 be part of everything. It often means working evenings to stay flexible during the day.鈥

The flexibility of the PhD program has been a great help to her, as it allows her to organize her work independently. After completing her PhD, she expects to begin specialist medical training:

鈥淚f we want to inspire people to go into research in the long term, it鈥檚 important to create good conditions that make it possible,鈥 says Adelina Yafasova.

That鈥檚 why she plans to use the DKK 200,000 research grant from the Lundbeck Foundation Talent Prize to buy herself time for research:

鈥淭hat way, I can continue my research while I鈥檓 training to become a specialist doctor after my PhD.鈥

Cardiac Sarcoidosis

Sarcoidosis is a relatively rare disease of the immune system in which the immune response becomes overactive. It can cause inflammation in many organs, most often the lungs, heart, lymph nodes, joints, and skin. The disease leads to the formation of granulomas 鈥 small nodules that can appear in any organ in the body.

In Denmark, the incidence of new cases of sarcoidosis is about 14.5 per 100,000 people per year, corresponding to approximately 855 new cases annually. The average age at diagnosis is 46, with a slight predominance of men. Denmark has one of the highest rates of sarcoidosis in the world.

It is estimated that about 5% of sarcoidosis patients have symptoms of cardiac sarcoidosis, but as many as 20鈥25% may have signs of cardiac sarcoidosis without symptoms.

Adelina Yafasova

(Foto: Privat)